Showing 1,341 - 1,360 results of 27,596 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (nn decrease)) ))', query time: 0.63s Refine Results
  1. 1341

    Identification of Two Plastid Proteins in the Dinoflagellate <i>Alexandrium affine</i> That Are Substantially Down-Regulated by Nitrogen-Depletion by Fred Wang-Fat Lee (2339839)

    Published 2009
    “…Five of these nine spots were all identified as isoforms of the plastid Form II ribulose-1,5 bisphosphate carboxylase/oxygenase (Rubisco II), while an additional four protein spots with a molecular weight of 50 kDa were identified as isoforms of a novel protein named nitrogen-associated protein 50 (NAP50). …”
  2. 1342

    Identification of Two Plastid Proteins in the Dinoflagellate <i>Alexandrium affine</i> That Are Substantially Down-Regulated by Nitrogen-Depletion by Fred Wang-Fat Lee (2339839)

    Published 2009
    “…Five of these nine spots were all identified as isoforms of the plastid Form II ribulose-1,5 bisphosphate carboxylase/oxygenase (Rubisco II), while an additional four protein spots with a molecular weight of 50 kDa were identified as isoforms of a novel protein named nitrogen-associated protein 50 (NAP50). …”
  3. 1343

    Identification of Two Plastid Proteins in the Dinoflagellate <i>Alexandrium affine</i> That Are Substantially Down-Regulated by Nitrogen-Depletion by Fred Wang-Fat Lee (2339839)

    Published 2009
    “…Five of these nine spots were all identified as isoforms of the plastid Form II ribulose-1,5 bisphosphate carboxylase/oxygenase (Rubisco II), while an additional four protein spots with a molecular weight of 50 kDa were identified as isoforms of a novel protein named nitrogen-associated protein 50 (NAP50). …”
  4. 1344
  5. 1345
  6. 1346

    AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

    Published 2018
    “…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”
  7. 1347
  8. 1348
  9. 1349
  10. 1350
  11. 1351
  12. 1352
  13. 1353
  14. 1354
  15. 1355

    <i>Sdc1</i><sup>-/-</sup> mice have normal leukocyte recruitment to the parietal peritoneum microcirculation. by Paulina M. Kowalewska (625078)

    Published 2014
    “…<p>Wild-type and <i>Sdc1</i><sup>-/-</sup> mice were injected IP with 50<i> µ</i>L of saline, <i>S. aureus</i> LTA (125<i> µ</i>g), <i>E. coli</i> LPS (125<i> µ</i>g) or TNF<i>α</i> (500 ng). …”
  16. 1356
  17. 1357
  18. 1358
  19. 1359
  20. 1360

    The effects of pretreatment with fingolimod-phosphate on BMECs in the presence of MS sera. by Hideaki Nishihara (545149)

    Published 2015
    “…Pretreatment with fingolimod-phosphate resulted in an increase in the claudin-5 protein levels (B) and TEER values (G) and a decrease in the VCAM-1 protein levels (F) in the BMECs, which were upregulated after exposure to the sera from all MS patients, including the RRMS-R, RRMS-S and SPMS patients, compared to that observed in the cells not pretreated with fingolimod-phosphate.…”